- Home
- Medical
- Radiology, Radiotherapy & Nuclear Medicine
- Handbook of Metastatic Breast Cancer
Handbook of Metastatic Breast Cancer
List Price:
$82.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Charles Swanton, Stephen R. D. Johnston
Format:
Paperback
Pages:
312
Publisher:
CRC Press (October 18, 2019)
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9780367382186
Weight:
16oz
Dimensions:
6.125" x 9.1875"
File:
TAYLORFRANCIS-TayFran_260415045548659-20260415.xml
Folder:
TAYLORFRANCIS
List Price:
$82.99
Country of Origin:
United States
Pub Discount:
30
Case Pack:
1
As low as:
$78.84
Publisher Identifier:
P-CRC
Discount Code:
H
Imprint:
CRC Press
Overview
Recent developments with novel systemic drugs, palliative surgical techniques, and diagnostic imaging have given hope for the treatment of patients whose breast cancer has spread beyond its primary tumor. Written by a team from leading cancer centers in Europe, including the UK's Royal Marsden Hospital, this book provides advanced scientific information and guidance on clinical problems associated with metastatic breast cancer. It discusses endocrine therapy, chemotherapy, targeted biologics, and bisphosphonates. It covers diagnostic imaging and tumor assessment; reviews management options for neurological, pulmonary, hepatic and orthopedic complications; and discusses palliative care.
